Global Other Stockholder Equity from 2010 to 2024

GMRE Stock  USD 8.86  0.16  1.84%   
Global Medical's Other Stockholder Equity is increasing over the years with slightly volatile fluctuation. Overall, Other Stockholder Equity is expected to go to about 758.5 M this year. During the period from 2010 to 2024 Global Medical Other Stockholder Equity annual values regression line had geometric mean of  20,332,191 and mean square error of 10265.5 T. View All Fundamentals
 
Other Stockholder Equity  
First Reported
2011-12-31
Previous Quarter
722.6 M
Current Value
733.6 M
Quarterly Volatility
295.3 M
 
Yuan Drop
 
Covid
Check Global Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Global Medical's main balance sheet or income statement drivers, such as Interest Expense of 32.4 M, Selling General Administrative of 10.9 M or Other Operating Expenses of 108.3 M, as well as many indicators such as Price To Sales Ratio of 4.24, Dividend Yield of 0.095 or PTB Ratio of 2.13. Global financial statements analysis is a perfect complement when working with Global Medical Valuation or Volatility modules.
  
Check out the analysis of Global Medical Correlation against competitors.

Latest Global Medical's Other Stockholder Equity Growth Pattern

Below is the plot of the Other Stockholder Equity of Global Medical REIT over the last few years. It is Global Medical's Other Stockholder Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Global Medical's overall financial position and show how it may be relating to other accounts over time.
Other Stockholder Equity10 Years Trend
Slightly volatile
   Other Stockholder Equity   
       Timeline  

Global Other Stockholder Equity Regression Statistics

Arithmetic Mean298,636,558
Geometric Mean20,332,191
Coefficient Of Variation104.39
Mean Deviation274,754,873
Median205,788,000
Standard Deviation311,734,463
Sample Variance97178.4T
Range758.5M
R-Value0.95
Mean Square Error10265.5T
R-Squared0.90
Slope66,199,003
Total Sum of Squares1360497.3T

Global Other Stockholder Equity History

2024758.5 M
2023722.4 M
2022722 M
2021711.4 M
2020504.8 M
2019433.3 M
2018243 M

About Global Medical Financial Statements

Global Medical stakeholders use historical fundamental indicators, such as Global Medical's Other Stockholder Equity, to determine how well the company is positioned to perform in the future. Although Global Medical investors may analyze each financial statement separately, they are all interrelated. For example, changes in Global Medical's assets and liabilities are reflected in the revenues and expenses on Global Medical's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Global Medical REIT. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Other Stockholder Equity722.4 M758.5 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Global Medical REIT is a strong investment it is important to analyze Global Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Global Medical's future performance. For an informed investment choice regarding Global Stock, refer to the following important reports:
Check out the analysis of Global Medical Correlation against competitors.
You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Is Diversified REITs space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Global Medical. If investors know Global will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Global Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.43)
Dividend Share
0.84
Earnings Share
(0.02)
Revenue Per Share
2.082
Quarterly Revenue Growth
(0.04)
The market value of Global Medical REIT is measured differently than its book value, which is the value of Global that is recorded on the company's balance sheet. Investors also form their own opinion of Global Medical's value that differs from its market value or its book value, called intrinsic value, which is Global Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Global Medical's market value can be influenced by many factors that don't directly affect Global Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Global Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Global Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Global Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.